Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Comparison of costs of sublingual immunotherapy and drug treatment in grass-pollen induced allergy: results from the SIMAP database study.

Comparison of costs of sublingual immunotherapy and drug treatment in grass-pollen induced allergy: results from the SIMAP database study. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Comparison of costs of sublingual immunotherapy and drug treatment in grass-pollen induced allergy: results from the SIMAP database study. Abstract Text:

    patrizia bertoPatrizia Berto,franco fratiFranco Frati,cristoforo incorvaiaCristoforo Incorvaia,gianni cadarioGianni Cadario,rosario contigugliaRosario Contiguglia,mario di gioacchinoMario Di Gioacchino,paola puccinelliPaola Puccinelli,gian enrico sennaGian Enrico Senna,carla valleCarla Valle,patrizia bertoPatrizia Berto,franco fratiFranco Frati,cristoforo incorvaiaCristoforo Incorvaia,gianni cadarioGianni Cadario,rosario contigugliaRosario Contiguglia,mario di gioacchinoMario Di Gioacchino,paola puccinelliPaola Puccinelli,gian enrico sennaGian Enrico Senna,carla valleCarla Valle,

    OBJECTIVES: This analysis is focused on the comparison of costs of allergic rhinitis (R) alone or with allergic asthma (R + A) in grass pollen allergy, for subjects treated with sublingual immunotherapy (SLIT) and symptomatic drugs, versus standard care controls. METHODS: The SIMAP (Sublingual IMmunotherapy in Allergic Patients) study is a longitudinal observational database operated by a network of Allergy centers. Patients suffering from grass pollen allergy were included in this analysis and assigned to SLIT (plus drugs as needed) or to treatment with drugs alone. Outcome measures included use of medications, SLIT, visits and tests. Costs were assessed from the perspective of the Italian National Health Service; unit costs were obtained from published sources to produce an average cost/patient for the first year after enrolment. RESULTS: One hundred and two patients were analyzed. Demographics were comparable in the two groups. Overall per patient yearly cost of treatment was higher in SLIT patients, both in the whole sample (euro311 vs. euro180/patient), in the R (euro288 vs. euro116) and R + A (euro362 vs. euro230) subpopulations, with R + A patients generating more costs than R patients in both groups. Nevertheless considerable savings were obtained in the cost of symptomatic drugs (-22% for R; -34% for R + A) in SLIT patients. CONCLUSIONS: Other studies have shown that SLIT can reduce the use of drugs for asthma and rhinitis, but this is the first time this outcome has been demonstrated in a routine care population (in the medical practice environment of an observational study) within the first year of treatment.

    Comparison of costs of sublingual immunotherapy and drug treatment in grass-pollen induced allergy: results from the SIMAP database study. Publishing Authors By Initials

    p bertoP Berto,f fratiF Frati,c incorvaiaC Incorvaia,g cadarioG Cadario,r contigugliaR Contiguglia,m di gioacchinoM Di Gioacchino,p puccinelliP Puccinelli,ge sennaGE Senna,c valleC Valle,p bertoP Berto,f fratiF Frati,c incorvaiaC Incorvaia,g cadarioG Cadario,r contigugliaR Contiguglia,m di gioacchinoM Di Gioacchino,p puccinelliP Puccinelli,ge sennaGE Senna,c valleC Valle,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Comparison of costs of sublingual immunotherapy and drug treatment in grass-pollen induced allergy: results from the SIMAP database study. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Current medical research and opinion

    VOLUME: 24

    Page Numbers: 261-6

    Journal Abbreviation:

    ISSN: 1473-4877

    DAY: 7

    MONTH: Jan

    YEAR: 2008

    Comparison of costs of sublingual immunotherapy and drug treatment in grass-pollen induced allergy: results from the SIMAP database study. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 351014

    Comparison of costs of sublingual immunotherapy and drug treatment in grass-pollen induced allergy: results from the SIMAP database study. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Comparison of costs of sublingual immunotherapy and drug treatment in grass-pollen induced allergy: results from the SIMAP database study. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Comparison of costs of sublingual immunotherapy and drug treatment in grass-pollen induced allergy: results from the SIMAP database study.

    AFFILIATION: School of Pharmacy, University of Padova, Italy; PBE Consulting, Verona, Italy.

    Country: England

    England Research PublicationEngland Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Curr Med Res Opin

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Comparison of costs of sublingual immunotherapy and drug treatment in grass-pollen induced allergy: results from the SIMAP database study Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News